Invesco Ltd. Mirati Therapeutics, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$41.99 - $62.38 $234,682 - $348,641	5,589 Added 9.3%	65,657 $3.86 Million
Q3 2023 Nov 13, 2023	SELL	$27.8 - $45.35 $667,311 - $1.09 Million	-24,004 Reduced 28.55%	60,068 $2.62 Million
Q2 2023 Aug 11, 2023	SELL	$36.13 - $49.49 $2.58 Million - $3.53 Million	-71,287 Reduced 45.89%	84,072 $3.04 Million
Q1 2023 May 12, 2023	SELL	$36.54 - $54.26 $10.2 Million - $15.1 Million	-278,217 Reduced 64.17%	155,359 $5.78 Million
Q4 2022 Feb 13, 2023	SELL	$41.27 - $98.62 $6.08 Million - $14.5 Million	-147,332 Reduced 25.36%	433,576 $19.6 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $8.22 Million - $12 Million	138,196 Added 31.22%	580,908 $40.6 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $615,712 - $1.39 Million	15,723 Added 3.68%	442,712 $29.7 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $2.24 Million - $4.47 Million	29,576 Added 7.44%	426,989 $35.1 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $38.5 Million - $55.5 Million	-291,501 Reduced 42.31%	397,413 $58.3 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $46.4 Million - $62.3 Million	350,818 Added 103.76%	688,914 $122 Million
Q2 2021 Aug 17, 2021	BUY	$144.0 - $179.73 $1.28 Million - $1.6 Million	8,916 Added 2.71%	338,096 $54.6 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $27.6 Million - $38.4 Million	-173,436 Reduced 34.51%	329,180 $56.4 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $1.72 Million - $2.55 Million	-10,604 Reduced 2.07%	502,616 $110 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $55 Million - $81.3 Million	485,943 Added 1781.51%	513,220 $85.2 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $234,680 - $392,351	-3,259 Reduced 10.67%	27,277 $3.11 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $30.2 Million - $50.3 Million	-433,134 Reduced 93.41%	30,536 $2.35 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $25.3 Million - $46.1 Million	-357,386 Reduced 43.53%	463,670 $59.7 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $14.2 Million - $19.9 Million	-181,739 Reduced 18.12%	821,056 $64 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $45.8 Million - $80.6 Million	769,429 Added 329.71%	1,002,795 $103 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $4.63 Million - $8.38 Million	106,130 Added 83.41%	233,366 $17.1 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $4.07 Million - $6.03 Million	127,236 New	127,236 $5.4 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account